From Investment to Deployment: Why Intellectual Property Matters in an Expanding Nuclear Energy Market
Key Takeaway: New federal initiatives are expanding access to private capital and deployment financing for nuclear energy technologies. Companies that fail to protect and clearly document their intellectual property may...
FDA Launches Expedited IND Pilot Program to Accelerate Human Trials, Raising IP Considerations for Sponsors
Key Takeaways: The Expedited Investigational New Drug (IND) Pilot Program is intended to evaluate whether leveraging qualified research institutions (QRIs) and a rolling review process can improve the efficiency of...
AI-Enabled Medical Devices Require an Integrated FDA and IP Strategy
Key Takeaway: Medical device companies should prepare a cohesive patent and premarket submission strategy by considering FDA recommendations when developing AI-enabled features and coordinating statements made to the Patent Office...